‘Yoohoo, Ventavia!’: Whistleblower faces off against Pfizer, Ventavia

“Yoohoo, Ventavia! I will expose every, single one of your secrets. You're going to love the documents section.” 

That was the tweet posted today by Brooke Jackson, the famous “Pfizer trial whistleblower”. Jackson, who worked as the regional director at Ventavia, was fired in 2020 for sounding the alarm on Pfizer’s COVID-19 mRNA clinical trials. 

Pfizer had contracted with Ventavia to oversee the crucial Phase III clinical trials that needed to be passed for the vaccine to be granted emergency use authorization by the Food and Drug Administration (FDA). Ventavia assigned Jackson to oversee two of the three clinical trial sites. 

But the clinical researcher says she was shocked by what she saw. 

“Although my time with this company was brief, the misconduct that I witnessed was so blatant and so widespread that I documented numerous violations of the U.S. Food and Drug Administration (FDA) Code of Federal Regulations every, single day,” wrote Jackson. 

She brought her concerns to Ventavia’s management and even submitted an anonymous complaint to Pfizer. 

But Jackson says that only made the corporations scramble to cover up the fraud. 

She filed a formal complaint with the FDA on September 25, 2020 and was fired that day. 

Jackson sued Ventavia and Pfizer for retaliation in January 2021, in addition to numerous counts of fraud. But she says she was “misled” by a team of attorneys and was put under a court-issued gag order. All the documented evidence supplied by Jackson were sealed by the court. 

On February 10, 2022, U.S. District Court Judge Michael Truncale ordered the evidence unsealed. Now, Jackson is moving ahead with the lawsuit and ready to bare all. 

Among Jackson’s allegations are that Ventavia, Pfizer and ICON – another clinical research group contracted by Pfizer – had “deliberately withheld crucial information from the United States that calls the safety and efficacy of their vaccine into question.” 

According to the suit, the companies also “concealed violations of both their clinical trial protocol and federal regulations, including falsification of clinical trial documents.” 

“Due to Defendants’ scheme, millions of Americans have received a misbranded vaccination which is potentially not as effective as represented,” alleges the lawsuit.